Skip to content

Exagen Inc. XGN Net Income

Net Income at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$277.8M+30.5%
Quest Diagnostics logo
Quest DiagnosticsDGX
$252M+14.5%
Vor Biopharma logo
Vor BiopharmaVOR
-$219.59M-576%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.63M-49.3%
CareDx logo
CareDxCDNA
$2.81M+127%
Revvity logo
RevvityRVTY
$40.72M-3.6%

Segments

By segment

See full
Reportable Segment-$3.93M-4.8%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s net income?
Exagen Inc. (XGN) reported net income of -$3.97M in Q1 2026.
How has Exagen Inc.'s net income changed year-over-year?
Exagen Inc.'s net income decreased by 5.7% year-over-year, from -$3.75M to -$3.97M.
What is the long-term trend for Exagen Inc.'s net income?
Over 4 years (2021 to 2025), Exagen Inc.'s net income has grown at a -7.2% compound annual growth rate (CAGR), from -$26.85M to -$19.95M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.